Ascend was founded to address the need for quality manufacturing capacity for any gene and cell therapy developer.
Ascend has raised €121M across 1 funding round, most recently a round in May 2023. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-09 | Other | €121M |
| — |
| View deal → |
